LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a product name.
REQUEST A FREE TRIAL
Product
Deals
Articles
BioCentury
|
Jan 9, 2018
Distillery Therapeutics
Autoimmune disease
Read More
BioCentury
|
Jan 11, 2017
Clinical News
Allergan discloses Phase II miss in LXR program
Read More
BioCentury
|
Nov 11, 2016
Clinical News
VTP-38543: Ph I/II data
Read More
BioCentury
|
Sep 19, 2016
Company News
Vitae, Allergan deal
Read More
BioCentury
|
Sep 14, 2016
Top Story
Allergan acquiring Vitae
Read More
BioCentury
|
Jan 25, 2016
Clinical News
VTP-38543: Phase IIa started
Read More
BioCentury
|
Dec 4, 2014
Distillery Therapeutics
Indication: Cardiovascular disease
Read More
Items per page:
10
1 - 7 of 7
